000			00364nam a22001097a 4500
008			220825b |||||||| |||| 00| 0 eng d
100			_aAGRAWAL, Ayushi
245			_aAn approach on current regulatory considerations of adverse event reporting & pharmacovigilance for biologics in India and US
300			_aviii, 148
502			_gMADHAVI B.L.R.
942			_2ddc _cT
999			_c397951 _d397951